676
Views
11
CrossRef citations to date
0
Altmetric
Author's View

The two faces of regulatory T cells in cancer

, &
Article: e23852 | Received 29 Jan 2013, Accepted 31 Jan 2013, Published online: 15 Apr 2013

References

  • Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pagès C, et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 2006; 313:1960 - 4; http://dx.doi.org/10.1126/science.1129139; PMID: 17008531
  • Khazaie K, Bonertz A, Beckhove P. Current developments with peptide-based human tumor vaccines. Curr Opin Oncol 2009; 21:524 - 30; http://dx.doi.org/10.1097/CCO.0b013e328331a78e; PMID: 19770763
  • Wilke CM, Kryczek I, Wei S, Zhao E, Wu K, Wang G, et al. Th17 cells in cancer: help or hindrance?. Carcinogenesis 2011; 32:643 - 9; http://dx.doi.org/10.1093/carcin/bgr019; PMID: 21304053
  • Khazaie K, Blatner NR, Khan MW, Gounari F, Gounaris E, Dennis K, et al. The significant role of mast cells in cancer. Cancer Metastasis Rev 2011; 30:45 - 60; http://dx.doi.org/10.1007/s10555-011-9286-z; PMID: 21287360
  • Gounaris E, Blatner NR, Dennis K, Magnusson F, Gurish MF, Strom TB, et al. T-regulatory cells shift from a protective anti-inflammatory to a cancer-promoting proinflammatory phenotype in polyposis. Cancer Res 2009; 69:5490 - 7; http://dx.doi.org/10.1158/0008-5472.CAN-09-0304; PMID: 19570783
  • Blatner NR, Bonertz A, Beckhove P, Cheon EC, Krantz SB, Strouch M, et al. In colorectal cancer mast cells contribute to systemic regulatory T-cell dysfunction. Proc Natl Acad Sci U S A 2010; 107:6430 - 5; http://dx.doi.org/10.1073/pnas.0913683107; PMID: 20308560
  • Blatner NR, Mulcahy MF, Dennis KL, Scholtens D, Bentrem DJ, Phillips JD, et al. Expression of RORγt marks a pathogenic regulatory T cell subset in human colon cancer. Sci Transl Med 2012; 4:ra159; http://dx.doi.org/10.1126/scitranslmed.3004566; PMID: 23241743
  • Tosolini M, Kirilovsky A, Mlecnik B, Fredriksen T, Mauger S, Bindea G, et al. Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer. Cancer Res 2011; 71:1263 - 71; http://dx.doi.org/10.1158/0008-5472.CAN-10-2907; PMID: 21303976
  • Bos PD, Rudensky AY. Treg cells in cancer: a case of multiple personality disorder. Sci Transl Med 2012; 4:64fs44; http://dx.doi.org/10.1126/scitranslmed.3005283; PMID: 23241741
  • Erdman SE, Poutahidis T. Cancer inflammation and regulatory T cells. Int J Cancer 2010; 127:768 - 79; PMID: 20518013